Acute Effects of Motor Imagery Exercises in Individuals With Pregnancy-Related Lumbopelvic Pain

July 13, 2026 updated by: Hasan Gerçek, KTO Karatay University
The aim of this study is to investigate the effects of single-session motor imagery exercises on pain and motor imagery in individuals with pregnancy-related lumbopelvic pain.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Be in a singleton, uncomplicated pregnancy.
  • Lumbopelvic pain (lower back or pelvic girdle pain) must have begun during pregnancy.
  • Be between the 12th and 40th weeks of pregnancy.
  • Be capable of understanding motor imagery training and following instructions.

Exclusion Criteria:

  • A history of chronic lower back pain present before pregnancy and persisting during pregnancy.
  • Symptoms of neuropathic lower back pain (e.g., radiculopathy), inflammatory conditions such as tumors, infections, compression fractures, or ankylosing spondylitis that are specific causes of lower back or pelvic pain, a history of previous spinal or pelvic surgery,
  • Severe neurological disorders, metabolic disorders, or severe orthopedic conditions,
  • Medical restrictions that prevent exercise or maintaining certain positions (e.g., lying on the back).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
Other: Placebo Motor Imagery Exercise
A single session of placebo motor imagery exercise will be performed according to the PETTLEP model.
Experimental: Motor Imagery
Device: Motor Imagery Exercise
A single session of motor imagery exercise will be performed according to the PETTLEP model.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor Imagery
Time Frame: Baseline and immediately post-intervention
Motor imagery ability will be assessed using the Movement Imagery Questionnaire (MIQ). The questionnaire consists of items assessing visual imagery (clarity of the image) and kinesthetic imagery (intensity of the sensation). Each item is scored on a 7-point scale (1 = very hard to imagine, 7 = very easy to imagine). Subscale scores (visual and kinesthetic) and a total score will be calculated. Higher scores indicate better motor imagery ability.
Baseline and immediately post-intervention
Pain Severity
Time Frame: Baseline and immediately post-intervention
The pain of the participants will be evaluated with a 10 cm Visual Analog Scale before the treatment and at the end of the application. "0" means no pain, "10" means excruciating pain. Results will be recorded in cm.
Baseline and immediately post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

KTO Karatay University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2026

Primary Completion (Actual)

July 12, 2026

Study Completion (Actual)

July 13, 2026

Study Registration Dates

First Submitted

April 1, 2026

First Submitted That Met QC Criteria

April 1, 2026

First Posted (Actual)

April 8, 2026

Study Record Updates

Last Update Posted (Actual)

July 14, 2026

Last Update Submitted That Met QC Criteria

July 13, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • KaratayUH18

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe